Skip to main content

Advertisement

Log in

Application of fusogenic liposomes containing fragment A of diphtheria toxin to cancer therapy

  • Experimental Oncology
  • Published:
British Journal of Cancer Submit manuscript

Abstract

Previously we reported that fusogenic liposomes, prepared by fusing simple liposomes with Sendai virus particles, could introduce their contents directly and efficiently into the cytoplasm. In this study, we examined the anti-tumour activity of fusogenic liposomes containing fragment A of diphtheria toxin (DTA). Fusogenic liposomes containing DTA showed high cytotoxicity against sarcoma-180 (S-180) cells in vitro. When these liposomes were administered into the abdominal cavity of ddY mice carrying S-180, tumour cells completely disappeared in four of six tumour-bearing mice without decrease in body weight. Neither simple liposomes containing DTA nor empty fusogenic liposomes had any effect on tumour suppression. We conclude that fusogenic liposomes containing DTA are new and potentially effective tools for the treatment of ascites tumours without any severe side-effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mizuguchi, H., Nakanishi, M., Nakanishi, T. et al. Application of fusogenic liposomes containing fragment A of diphtheria toxin to cancer therapy. Br J Cancer 73, 472–476 (1996). https://doi.org/10.1038/bjc.1996.83

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/bjc.1996.83

  • Springer Nature Limited

This article is cited by

Navigation